Search Results

Search Results

No Results Found

Try adjusting your search to find what you’re looking for.

Cell Therapy: Regulatory compliant human AB serum

Case Studies
Feb 11, 2023
Middle Eastern-based, clinical stage Cell Therapy company needed to reduce risk and potential concerns from the US FDA regarding cell culture products with animal components.

BioPharma: Improved workflow via collaboration

Case Studies
Feb 12, 2023
US-based $1B market cap biotechnology company focused on therapeutic antibodies lacked the internal cGMP liquid manufacturing capabilities to support their projects once they reach pilot scale, and required nimble partner to rapidly manufacture and adjust buffers for process optimization.

BioPharma: CDMO requires quality, speed, and service

Case Studies
Feb 12, 2023
Southeast US-based biologic drug contract development and manufacturing organization (CDMO) supporting early-stage product development to cGMP commercial manufacturing had experienced significant challenges finding CMO partners willing and able to address their needs, which included small to large cGMP batch sizes, short lead times, as well as services related to stability studies for new solutions.

Research: Core lab improves customer service

Case Studies
Feb 12, 2023
Northeast US-based core laboratory supporting multiple research labs was expending limited resources on down packaging FBS into smaller sized packaging (100mL) to simplify the process of aliquoting FBS by the labs and researchers supported by the core lab.

Cell Therapy: Scaling to cGMP buffers 

Case Studies
Feb 12, 2023
US-based Cell Therapy company that is part of a global > $50B market cap biopharmaceutical company needed an external manufacturer who could make cGMP process liquids – cost effectively – in the small aliquots required for their current workflow process steps.

Life Science Tools:  Outsource lab scale liquids

Case Studies
Feb 13, 2023
APAC-based, > $15B market cap, global cell culture tools company focused on leveraging self-manufacturing footprint for higher-value proprietary media products and custom manufacturing for end customers.